Skip to main content
Equibles

STATE STREET CORP

Position in NERV — Minerva Neurosciences, Inc.

CIK 93751 BOSTON, MA
Back to NERV Full portfolio

Position in NERV

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$2,358,278
+$2,018,776 QoQ
Shares Held
424,915
+654.1% QoQ
Ownership
0.890%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 58 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 46% Shared 0% None 54%

Common Shares in NERV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. NERV ranks #263 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in NERV

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,358,278 424,915
2026-03-31 $339,502 56,349
2025-12-31 $96,556 24,019
2025-09-30 $34,772 16,519
2025-06-30 $28,412 16,519
2025-03-31 $28,082 16,519
2024-12-31 $36,705 16,519
2024-09-30 $44,105 16,519
2024-06-30 $52,695 16,519
2024-03-31 $42,619 16,519
2023-12-31 $101,591 16,519
2023-09-30 $113,981 16,519
2023-06-30 $125,391 13,719
2023-03-31 $21,950 13,719
2022-12-31 $21,813 13,719
2022-09-30 $126,626 13,719
2022-06-30 $45,409 13,719
2022-03-31 $91,102 109,762
2021-12-31 $88,616 110,632
2021-09-30 $192,499 110,632
2021-06-30 $256,666 110,632
2021-03-31 $1,663,780 569,788
2020-12-31 $1,394,735 596,041
2020-09-30 $1,941,673 610,589
2020-06-30 $2,011,257 557,135
2020-03-31 $3,101,221 515,153